A citation-based method for searching scientific literature




David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
Times Cited: 3185




List of shared articles



Times cited


Cardiovascular disease in patients with type 1 diabetes: Early evaluation, risk factors and possible relation with cardiac autoimmunity.
Mei Shi, Rong Tang, Fansu Huang, Ting Zhong, Yan Chen, Xia Li, Zhiguang Zhou. Diabetes Metab Res Rev 2021
3

Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: The DCCT/EDIC study.
Ionut Bebu, Barbara H Braffett, Trevor J Orchard, Gayle M Lorenzi, David M Nathan, William H Herman, John M Lachin. Diabetes Res Clin Pract 2021
2

Cardiovascular disease in diabetes, beyond glucose.
Robert H Eckel, Karin E Bornfeldt, Ira J Goldberg. Cell Metab 2021
1

Diabetic dyslipidaemia.
Subashini C Thambiah, Leslie Charles Lai. Pract Lab Med 2021
0

The legacy effect in diabetes: are there long-term benefits?
Rachel Folz, Neda Laiteerapong. Diabetologia 2021
0




Respective Contributions of Glycemic Variability and Mean Daily Glucose as Predictors of Hypoglycemia in Type 1 Diabetes: Are They Equivalent?
Louis Monnier, Anne Wojtusciszyn, Nicolas Molinari, Claude Colette, Eric Renard, David Owens. Diabetes Care 2020
15

Cost-effectiveness of dapagliflozin as an adjunct to insulin for the treatment of type 1 diabetes mellitus in the United Kingdom.
Hayley Bennett, Amarjeet Tank, Marc Evans, Klas Bergenheim, Phil McEwan. Diabetes Obes Metab 2020
3


Applications and pitfalls of hemoglobin A1C and alternative methods of glycemic monitoring.
Michelle D Lundholm, Mary Ann Emanuele, Alina Ashraf, Sarah Nadeem. J Diabetes Complications 2020
6

Rationale for Timely Insulin Therapy in Type 2 Diabetes Within the Framework of Individualised Treatment: 2020 Update.
Markolf Hanefeld, Holger Fleischmann, Thorsten Siegmund, Jochen Seufert. Diabetes Ther 2020
3

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor.
Avital Nahmias, Priska Stahel, Changting Xiao, Gary F Lewis. Front Cardiovasc Med 2020
1

Legacy effect of intensive glucose control on major adverse cardiovascular outcome: Systematic review and meta-analyses of trials according to different scenarios.
Francesco Prattichizzo, Paola de Candia, Valeria De Nigris, Antonio Nicolucci, Antonio Ceriello. Metabolism 2020
13

Improved Time in Range Over 1 Year Is Associated With Reduced Albuminuria in Individuals With Sensor-Augmented Insulin Pump-Treated Type 1 Diabetes.
Ajenthen G Ranjan, Signe V Rosenlund, Tine W Hansen, Peter Rossing, Steen Andersen, Kirsten Nørgaard. Diabetes Care 2020
14


ASIAN PACIFIC SOCIETY OF NEPHROLOGY CLINICAL PRACTICE GUIDELINE ON DIABETIC KIDNEY DISEASE.
Adrian Liew, Sunita Bavanandan, Narayan Prasad, Muh Geot Wong, Jer Ming Chang, Somchai Eiam-Ong, Chuan-Ming Hao, Chiao Yuen Lim, Soo Kun Lim, Kook-Hwan Oh,[...]. Nephrology (Carlton) 2020
3

A primer on metabolic memory: why existing diabesity treatments fail.
Sidar Copur, Peter Rossing, Baris Afsar, Alan A Sag, Dimitrie Siriopol, Masanari Kuwabara, Alberto Ortiz, Mehmet Kanbay. Clin Kidney J 2020
0

The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
Neda Laiteerapong, Sandra A Ham, Yue Gao, Howard H Moffet, Jennifer Y Liu, Elbert S Huang, Andrew J Karter. Diabetes Care 2019
111